MedPath

Development and Effectiveness of ELMT in Comparison with MCT in Patients with Primary MTD

Not Applicable
Conditions
Muscle Tension Dysphonia (MTD).
Voice and resonance disorders
Registration Number
IRCT20211110053027N1
Lead Sponsor
Tehran University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
30
Inclusion Criteria

In the present study, those MTD patients will enter the study who have the following criteria: After being informed of the conditions and manner of conducting the study, express their informed consent to participate in the study;
2. Be in the age range of 20 to 55 years and all be women;
3. More than three months have passed since the voice or voice-related complaints;
4. Receive a primary MTD diagnosis based on the consensus of the laryngologist and speech and language pathologist and the results of voice history, consensus auditory-perceptual evaluation of voice, palpation, and video laryngoscopy;
Receive voice therapy or other voice-related therapies while performing the study.

Exclusion Criteria

Received voice therapy or other voice-related therapies for 90 days prior to the start of the study;
Have had an upper respiratory tract infection or a cold during the study and up to three weeks before;
Mass, wound or scar, presence of high fat tissue, history of surgery and radiotherapy in the neck area;
Be during breastfeeding and pregnancy;
Have an addiction to tobacco, drugs and alcohol;
There are neurological disorders involving the larynx, hearing disorders, head and neck surgeries, and behavioral and psychological disorders.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath